Dr. Peter Schulam

Peter G. Schulam, MD, PhD, is the Chief Scientific Officer, Johnson & Johnson MedTech. In this role, Peter leads the medical, clinical & pre-clinical teams for J&J MedTech to deliver innovative solutions to address unmet medical and clinical needs. He and his team provide deep medical, clinical, and scientific insight that accelerates innovation, value and safety for patients and customers everywhere through strong leadership and partnership with innovation and business partners across Johnson & Johnson. Peter is also the Leader, Office of Digital Innovation (ODI) at Johnson & Johnson MedTech. In this role, Peter leads the ODI team’s overarching digital strategy to support the company’s evolution to becoming more integrated and digitally powered. ODI along with JJT is enabling a digital surgery ecosystem with a unified platform to drive innovation and cross-enterprise digital partnership; offering standardized solutions and operations to increase organizational efficiency and reduce outcome variability; and engaging in strategic partnerships (e.g., Microsoft) to enable and empower J&J MedTech’s digital architecture

Since 2012, Peter has served as the Chair of the Department of Urology at Yale School of Medicine and Chief of the Department of Urology at Yale New Haven Hospital. He is a professor of both urology and surgery and as a clinician, is nationally recognized for his expertise in minimally invasive surgery, robotics and telesurgery. Peter served as Interim Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital from September 2015 through December 2016. In addition to his focus on patient care, Peter is Cofounder of the Yale University Center for Biomedical and Interventional Technology, an interdisciplinary initiative to foster greater innovation in medical technology by catalyzing medical device innovation, improving clinical efficiency and efficacy, and lowering healthcare costs. In June 2018, he was also named Chief Innovation and Transformation Officer at Yale New Haven Health System. Prior to joining Yale, Peter was the Henry E. Singleton Professor of Urology at the Ronald Reagan Medical Center at University of California, Los Angeles where he served as Vice Chair of Urology, Chief of the Division of Endourology and Minimally Invasive Surgery, and Director of the Surgical Living Kidney Donor program. Peter was a recipient of the Medical Scientist Training Program award and received his Medical Degree as well as his PhD in Immunology at Baylor College of Medicine in Houston. He completed his urology residency at The Johns Hopkins Hospital in Baltimore. Peter is known for his research, having received more than $17 million in grants throughout his career. 

He holds multiple patents, has more than 90-peer reviewed publications, contributed chapters to 14 books, and has presented and lectured at more than 150 medical meetings around the world.